These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 6111198)

  • 1. Experimental basis of enhancing the immunogenicity of influenza B virus by genetic recombination.
    Medvedeva TE; Gordon MA; Aleksandrova GI; Smorodintsev AA
    Acta Virol; 1980 Dec; 24(6):385-90. PubMed ID: 6111198
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Attenuated influenza B virus recombinants obtained by crossing of B/England/2608/76 virus with a cold-adapted B/Leningrad/14/17/55 strain.
    Medvedeva TE; Gordon MA; Ghendon YZ; Klimov AI; Alexandrova GI
    Acta Virol; 1983 Jul; 27(4):311-7. PubMed ID: 6195900
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preparation of influenza B virus recombinant strains.
    Podchernyaeva RYa ; Shchipanova MV; Elkin VS; Melnichenko EI
    Acta Virol; 1987 Nov; 31(6):475-80. PubMed ID: 2894141
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protection of mice against lethal infection with highly pathogenic H7N7 influenza A virus by using a recombinant low-pathogenicity vaccine strain.
    de Wit E; Munster VJ; Spronken MI; Bestebroer TM; Baas C; Beyer WE; Rimmelzwaan GF; Osterhaus AD; Fouchier RA
    J Virol; 2005 Oct; 79(19):12401-7. PubMed ID: 16160167
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Experiments in the preparation of live influenza B vaccines.
    Beare AS; Sherwood JE; Callow KA; Craig JW
    Dev Biol Stand; 1977 Jun 1-3; 39():85-9. PubMed ID: 604138
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antigenic drift and variability of influenza viruses.
    Schweiger B; Zadow I; Heckler R
    Med Microbiol Immunol; 2002 Dec; 191(3-4):133-8. PubMed ID: 12458347
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Relations between human and animal influenza viruses].
    Mihail A
    Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Bacteriol Virusol Parazitol Epidemiol; 1977; 22(3):129-40. PubMed ID: 144990
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Attenuated ts-recombinants of influenza A/USSR/77 (H1N1) virus obtained by crossing with the cold-adapted donor A/Leningrad/134/57 (H2N2) virus.
    Polezhaev FI; Garmashova LM; Koval TA; Taranova GP; Topuriya NV; Aleksandrova GI
    Acta Virol; 1982 Jul; 26(4):221-6. PubMed ID: 6127928
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Genome of influenza virus: organization, function, evolution].
    Kaverin NV
    Mol Biol (Mosk); 1980; 14(2):245-60. PubMed ID: 6991913
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Immunogenicity of recombinant influenza virus vaccines (author's transl)].
    Higashihara M; Suzuki Y; Saito Y; Igarashi Y; Yoshioka I; Takahashi M; Miki Y
    Uirusu; 1979 Dec; 29(2):127-39. PubMed ID: 550564
    [No Abstract]   [Full Text] [Related]  

  • 11. Comparative studies on biological properties and genome composition of influenza virus recombinants.
    Podchernyaeva RYa ; Blinova VK; Sokolova NN; Farashyan VR; Zhdanov VM; Irzhanov SD; Lvov DK; Ghendon YuZ
    Acta Virol; 1983 May; 27(3):209-16. PubMed ID: 6138981
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular characteristics and biological properties (genetic markers) of candidate strains for preparation of live influenza virus vaccines.
    Ghendon YZ
    Bull World Health Organ; 1984; 62(3):493-9. PubMed ID: 6331910
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Genetics of influenza viruses].
    Döhner L
    Arch Exp Veterinarmed; 1978; 32(3):399-406. PubMed ID: 697527
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recombinant influenza-virus vaccines. IV. Segregation of antigenic and some biological properties of Influenza virus neuraminidase by recombination.
    Higashihara M; Igarashi Y; Saito Y
    Kitasato Arch Exp Med; 1976 Sep; 49(3):81-91. PubMed ID: 1029759
    [No Abstract]   [Full Text] [Related]  

  • 15. [Preparative isolation of myxovirus glycoproteins and the study of their immunogenic properties].
    Berezin VE; Zaĭdes VM; Mchedlishvili BV; Selimova LM; Kliushnik SIu
    Mol Gen Mikrobiol Virusol; 1985 Jul; (7):36-43. PubMed ID: 3025716
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunologic response to influenza virus infection.
    Krystal M
    Immunol Ser; 1989; 43():597-621. PubMed ID: 2562311
    [No Abstract]   [Full Text] [Related]  

  • 17. Enhanced virulence of influenza A viruses with the haemagglutinin of the 1918 pandemic virus.
    Kobasa D; Takada A; Shinya K; Hatta M; Halfmann P; Theriault S; Suzuki H; Nishimura H; Mitamura K; Sugaya N; Usui T; Murata T; Maeda Y; Watanabe S; Suresh M; Suzuki T; Suzuki Y; Feldmann H; Kawaoka Y
    Nature; 2004 Oct; 431(7009):703-7. PubMed ID: 15470432
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peculiarities of influenza infection caused by highly and poorly immunogenic strains of influenza virus.
    Frolov AF; Skripchenko GS; Shcherbinskaya AM; Vlasova AG; Rybakova TM
    J Hyg Epidemiol Microbiol Immunol; 1984; 29(3):303-9. PubMed ID: 6544322
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Replicon-helper systems from attenuated Venezuelan equine encephalitis virus: expression of heterologous genes in vitro and immunization against heterologous pathogens in vivo.
    Pushko P; Parker M; Ludwig GV; Davis NL; Johnston RE; Smith JF
    Virology; 1997 Dec; 239(2):389-401. PubMed ID: 9434729
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phenotypic properties resulting from directed gene segment reassortment between wild-type A/Sydney/5/97 influenza virus and the live attenuated vaccine strain.
    Parks CL; Latham T; Cahill A; O'neill RE; Passarotti CJ; Buonagurio DA; Bechert TM; D'Arco GA; Neumann G; Destefano J; Arendt HE; Obregon J; Shutyak L; Hamm S; Sidhu MS; Zamb TJ; Udem SA
    Virology; 2007 Oct; 367(2):275-87. PubMed ID: 17599381
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.